In 2014 WHO recommended offering PrEP to men who have sex with men (MSM). On the
basis of further evidence of the effectiveness and acceptability of PrEP, WHO has now …

Reducing the incidence of HIV remains one of our greatest public health challenges.
However, there is growing optimism that preexposure prophylaxis (PrEP) could have a …

Objective: Recent studies have demonstrated the efficacy of antiretroviral preexposure
prophylaxis (PrEP) for prevention of HIV-1 infection. The purpose of this study was to identify …

Daily oral pre-exposure prophylaxis (PrEP) is the use of antiretroviral drugs by HIV-negative
people to prevent HIV infection. WHO released new guidelines in 2015 recommending PrEP …

Objective To conduct a systematic review and meta-analysis of randomised controlled trials
(RCTs) of the effectiveness and safety of oral pre-exposure prophylaxis (PrEP) to prevent …

HIV pre-exposure prophylaxis (PrEP) should be free across Canada for all those who meet
evidence-based guidelines. PrEP is a highly effective tool for preventing HIV acquisition that …

Preexposure prophylaxis (PrEP), in which HIV-uninfected persons with ongoing HIV risk use
antiretroviral medications to reduce their risk of acquiring HIV infection, is an efficacious and …

Objectives Pre‐exposure prophylaxis (PrEP) has proven biological efficacy in reducing the
risk of sexual acquisition of HIV. Healthcare providers'(HCPs) knowledge of and attitudes to …

The US Food and Drug Administration (FDA) has approved the use of Truvada®(a fıxed-
dose combination of emtricitabine and tenofovir disoproxil fumarate) as pre-exposure …

Pre-exposure prophylaxis (PrEP) is a new biomedical intervention for HIV prevention. This
study systematically reviews the acceptability of PrEP among men who have sex with men …